 | Up a level |
Journal Article
Dummer, Reinhard, Sandhu, Shahneen Kaur, Miller, Wilson H., Butler, Marcus O., Blank, Christian U., Munoz-Couselo, Eva, Burris, Howard A., III, Postow, Michael A., Chmielowski, Bartosz, Middleton, Mark R., Berking, Carola, Hassel, Jessica Cecile, Gesierich, Anja, Mauch, Cornelia, Kleha, Joseph, Gollerkeri, Ashwin, Harney, Allison, Pickard, Michael D. and Ascierto, Paolo Antonio (2020). A phase II, multicenter study of encorafenib/binimetinib followed by a rational triple-combination after progression in patients with advanced BRAF V600-mutated melanoma (LOGIC2). J. Clin. Oncol., 38 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Menzer, Christian, Menzies, Alexander M., Carlino, Matteo S., Reijers, Irene, Groen, Emma J., Eigentler, Thomas, de Groot, Jan Willem B., van der Veldt, Astrid A. M., Johnson, Douglas B., Meiss, Frank, Schlaak, Max, Schilling, Bastian, Westgeest, Hans M., Gutzmer, Ralf, Pfoehler, Claudia, Meier, Friedegund, Zimmer, Lisa, Suijkerbuijk, Karijn P. M., Haalck, Thomas, Thoms, Kai-Martin, Herbschleb, Karin, Leichsenring, Jonas, Menzer, Alexander, Kopp-Schneider, Annette, Long, Georgina V., Kefford, Richard 
ORCID: 0000-0001-9251-9229, Enk, Alexander, Blank, Christian U. and Hassel, Jessica C.
(2019).
Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations.
J. Clin. Oncol., 37 (33).
S. 3142 - 3163.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755